Bispecifics

The role of bispecific antibodies in the treatment landscape for R/R ...

Wendy Osborne, MBBS (Hons), MRCP, FRCPath, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK, provides insight into the role ...

Bispecifics – Expanding the potential of immunotherapies

Bispecifics – Expanding the potential of immunotherapies ... Bispecific antibodies are engineered to combine two epitope targeting regions into ...

What are Bispecific Monoclonal Antibodies? - News-Medical

What are Bispecific Monoclonal Antibodies? ... Bispecific antibodies are artificial proteins that have promising applications in the field of cancer immunotherapy ...

Utilization Challenges Hold Back the Adoption of Bispecific Therapies

Bispecific antibodies are a powerful class of therapy that offer an alternative or complement to CAR T-cell therapies, but there are similar ...

TCR Bispecifics - Immatics

TCER are off-the-shelf biologics that leverage the body's immune system by redirecting and activating T cells towards cancer cells expressing specific tumor ...

Should bispecifics or CAR-T be given first in R/R FL? - YouTube

Martin Hutchings, MD, PhD, Copenhagen University Hospital, Copenhagen, Denmark, provides an insight into the debate on whether bispecific ...

Bispecific Antibody Engineering - Genedata

Advancing Bispecific Antibody Discovery. Genedata Biologics® enables the systematic design, cloning, and testing of large numbers of bi- and multi-specifics, ...

Expanding Access to Cellular and Bispecific Therapies - SITC

SITC and ACCC gathered experts tasked with providing recommendations for centers interested in opening cellular therapy and bispecific programs.

Learnings from FDA‐Approved Bispecific Antibodies in Oncology ...

Bispecific antibodies, by enabling the targeting of more than one disease-associated antigen or engaging immune effector cells, ...

Bispecific Antibody Production Services | Sino Biological

With strong expertise and experience in recombinant antibody production, Sino Biological offers rapid and efficient bispecific antibody expression services.

Session 6: Insights from Health Care Systems on Bispecifics

Binod Dhakal, MD, MS, and a panel of experts in multiple myeloma provide a look at an upcoming Cancer Network Training Academy program discussing how to ...

Bispecific Antibodies: How They Are Designed to Work to Treat ...

The bispecific antibody brings the T cell in close proximity to the target cell, activating the release of cancer cell-killing proteins from the ...

Bispecific Antibody - GenScript

Using recombinant DNA technology, Bispecific IgG antibodies can be assembled from two different heavy and light chains expressed in the same cell line. But ...

bYlok® Bispecific Pairing Technology | Antibody Design - Lonza

Bispecific antibodies generated using Lonza's bYlok® technology display >95% correct HC-LC pairing* giving you access to a close-to-nature solution for an IgG- ...

Bispecific Antibody (BsAb) Cytokine Release Syndrome (CRS) and ...

BiSpecific Antibodies (BsAb): Contains 2 different target specific units in one antibody molecule. In oncology, these BsAbs generally link malignant cells ...

Addressing Challenges When Implementing Bispecific Antibodies in ...

There are some considerations when onboarding bispecific antibodies. Notably, site of care is a major consideration when onboarding bispecifics.

anti-ALFA Bispecifics - NanoTag Biotechnologies

These anti-ALFA/anti-IgG (various subtypes available) bi-specitifics can be used to target monoclonals to ALFA-tagged proteins. By using this modular systems ...

Bispecific Immune Cell Engager - Astellas Pharma Inc.

Astellas aims to provide new treatment options for patients with diseases for which there is no effective treatment by combining these approaches of ...

Bispecific Antibodies: From Research to Clinical Application - Frontiers

Bispecific antibodies (BsAbs) are antibodies with two binding sites directed at two different antigens or two different epitopes on the same antigen.

Bispecific Antibodies for Myeloma Treatment

Bispecific antibodies are a novel form of immunotherapy where we can bring together a myeloma cell and a T cell to treat a patient's myeloma.